Nichole Leatherwood
Family · San Antonio, TXNPI 1831649045
Payments from drug & device makers
Across 221 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$520
- AbbVie$403
- Biohaven Pharmaceuticals, Inc.$356
- AstraZeneca$260
- Lilly USA, LLC$233
- Avanir Pharmaceuticals, Inc.$197
- plus $1K from 29 others
What the payments were for
- Food & beverage$3,250100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $520 |
| AbbVie(2 entities) | 31 | $403 |
| Biohaven Pharmaceuticals, Inc. | 19 | $356 |
| AstraZeneca | 15 | $260 |
| Lilly USA, LLC | 25 | $233 |
| Avanir Pharmaceuticals, Inc. | 13 | $197 |
| Merck | 11 | $175 |
| Amgen | 8 | $146 |
| Nestle Healthcare Nutrition Inc. | 8 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $76 |
| Astellas Pharma US Inc | 4 | $60 |
| Eisai Inc. | 3 | $53 |
| Si-bone, Inc. | 1 | $50 |
| Sunovion Pharmaceuticals Inc. | 3 | $47 |
| Ultragenyx Pharmaceutical Inc. | 3 | $44 |
| Johnson & Johnson | 3 | $43 |
| Althera Pharmaceuticals LLC | 3 | $39 |
| Boehringer Ingelheim | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $32 |
| Novartis | 2 | $28 |
| GSK | 2 | $25 |
| Vistapharm, Inc. | 2 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Lupin Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Clarus Therapeutics Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Pfizer | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Upsher-smith Laboratories LLC | 1 | $12 |
| Abbott | 1 | $12 |
How this compares
$3,250 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 12 | $111 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $105 |
| Doxycycline Hyclate | 15 | $95 |
| Prednisone | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Ayoade AvworoSan Antonio$111K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.